Download PDF
Thromb Haemost 2011; 106(02): 263-264
DOI: 10.1160/TH11-02-0064
Theme Issue Article
Schattauer GmbH

Immunity to thrombotic events is achievable if we stop the guessing game: Is this the major hidden message from GRAVITAS?

Paul A. Gurbel
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Udaya S. Tantry
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Kevin P. Bliden
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Young-Hoon Jeong
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
› Author Affiliations Financial support: The study was supported by Sinai Center for Thrombosis Research.
Further Information

Publication History

Received: 02 February 2011

Accepted after major revision: 18 March 2011

Publication Date:
25 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Price MJ. The GRAVITAS (Gauging Responsiveness with A VerifyNow as say-Imp act on Thrombosis And Safety) trial. Talk presented at the American Heart Association 2010 Scientific Sessions. November 2010. Chicago, IL, USA.:
    Search in Google Scholar
  • 2 Gurbel PA, Becker RC, Mann KG. et al. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007; 50: 1822-1834.
    CrossrefPubMedSearch in Google Scholar
  • 3 Wiviott SD, Trenk D, Frelinger AL. et al. PRIN-CIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007; 116: 2923-2932.
    CrossrefPubMedSearch in Google Scholar
  • 4 Gurbel PA, Bliden KP, Butler K. et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009; 120: 2577-2585.
    CrossrefPubMedSearch in Google Scholar
  • 5 Gurbel PA, Bliden KP, Butler K. et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation 2010; 121: 1188-1199.
    CrossrefPubMedSearch in Google Scholar
  • 6 Bonello L, Tantry US, Marcucci R. et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010; 56: 919-933.
    CrossrefPubMedSearch in Google Scholar